193 related articles for article (PubMed ID: 30791934)
1. Strategy for treatment of stage IV human epidermal growth factor 2-positive gastric cancer: a case report.
Sakaguchi M; Shimoike N; Akagawa S; Kanaya S
J Med Case Rep; 2019 Feb; 13(1):42. PubMed ID: 30791934
[TBL] [Abstract][Full Text] [Related]
2. [Trastuzumab Combination Chemotherapy Followed by R0 Resection for Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer-A Case Report].
Takenoya T; Yabe N; Morishige S; Tamura E; Sakimoto Y; Tajima Y; Oto I; Yoshikawa T; Osumi K; Murai S
Gan To Kagaku Ryoho; 2019 Jan; 46(1):121-123. PubMed ID: 30765661
[TBL] [Abstract][Full Text] [Related]
3. Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer.
Cho JH; Lim JY; Cho JY
World J Gastroenterol; 2017 Nov; 23(41):7407-7414. PubMed ID: 29151694
[TBL] [Abstract][Full Text] [Related]
4. [Two cases of stage IV gastric cancer treated by resection of the primary tumor after chemotherapy combined with trastuzumab].
Nakayama Y; Kawasaki H; Wajima N; Kimura A; Nakai M; Yonaiyama S; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2188-90. PubMed ID: 24394055
[TBL] [Abstract][Full Text] [Related]
5. [A case of HER2-positive advanced gastric cancer successfully treated via capecitabine, cisplatin, and trastuzumab combination chemotherapy].
Endo S; Yamada T; Okuyama M; Hiraoka K; Konishi K; Kim C; Nakagawa T; Takeda K; Ueda Y; Matsumoto K; Nishikawa K; Nishijima J
Gan To Kagaku Ryoho; 2015 Mar; 42(3):359-61. PubMed ID: 25812508
[TBL] [Abstract][Full Text] [Related]
6. [A Case of HER2-Positive Stage IV Advanced Gastric Cancer Treated with Chemotherapy Combined with Trastuzumab].
Takaya K; Takahashi R; Honma S; Horii S; Takahashi H; Hagiwara M; Chin M; Hashizume E
Gan To Kagaku Ryoho; 2016 Sep; 43(9):1113-6. PubMed ID: 27628555
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Unresectable Advanced Gastric Cancer Resected by Conversion Surgery after Trastuzumab Combination Chemotherapy].
Hirai M; Hanyu T; Ichikawa H; Kano Y; Muneoka Y; Usui K; Ishikawa T; Ishikawa H; Miura K; Tajima Y; Nakano M; Takizawa K; Shimada Y; Sakata J; Wakai T
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1515-1517. PubMed ID: 36733120
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2.
Hayashi K; Nagasaki E; Nakada K; Tamura M; Arakawa Y; Uwagawa T; Yano S
J Infect Chemother; 2018 Apr; 24(4):298-301. PubMed ID: 29174919
[TBL] [Abstract][Full Text] [Related]
9. [A case of unresectable Stage IV HER2-positive advanced gastric cancer treated by using trastuzumab combined with chemotherapy].
Aomatsu N; Doi Y; Takemura S; Tanaka H; Muguruma K; Yui S; Hirakawa K
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1316-8. PubMed ID: 25335729
[TBL] [Abstract][Full Text] [Related]
10. Pathologic Response of HER2-positive Gastric Cancer to Trastuzumab-based Chemotherapy.
Urabe M; Ushiku T; Seto Y; Fukayama M
Am J Surg Pathol; 2016 Oct; 40(10):1326-33. PubMed ID: 27259008
[TBL] [Abstract][Full Text] [Related]
11. Intrapleural Trastuzumab Therapy for Malignant Pleural Effusion from HER2 Overexpression in Metastatic Gastric Cancer.
Orlandi E; Mordenti P; Zangrandi A; Cavanna L
Chemotherapy; 2014; 60(5-6):321-4. PubMed ID: 26279275
[TBL] [Abstract][Full Text] [Related]
12. [Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)].
Kim Y; Hosoda Y; Nishino M; Okano M; Kawada J; Yamasaki M; Nagai K; Yasui M; Okuyama M; Tsujinaka T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1635-7. PubMed ID: 26805121
[TBL] [Abstract][Full Text] [Related]
13. [Two Cases of Complete Response to Trastuzumab Combined with Chemotherapy for Recurrence of HER2-Positive Gastric Cancer].
Iwata M; Tabata M; Nakamura S; Nakamura S; Segi Y; Fujimura Y; Desaki R; Kobayashi M; Ohsawa I; Kato K; Sanda T
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2404-2406. PubMed ID: 32156946
[TBL] [Abstract][Full Text] [Related]
14. HER2-positive gastric cancer with paraaortic nodal metastasis successfully resected after chemotherapy with trastuzumab: a case report.
Ikari N; Nakajima G; Taniguchi K; Sasagawa T; Narumiya K; Yamada T; Kudo K; Kitamura Y; Hayashi K; Nishikawa T; Yamamoto M
Anticancer Res; 2014 Feb; 34(2):867-72. PubMed ID: 24511024
[TBL] [Abstract][Full Text] [Related]
15. [A Patient with HER2-Positive Stage IV Advanced Gastric Cancer Who Received Chemotherapy with Trastuzumab plus XP Followed by Conversion Surgery].
Yamamoto K; Yamamoto K; Maeda S; Uemura M; Miyake M; Hama N; Nishikawa K; Miyamoto A; Omiya H; Miyazaki M; Ikeda M; Hirao M; Takami K; Nakamori S; Sekimoto M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1942-1944. PubMed ID: 28133183
[TBL] [Abstract][Full Text] [Related]
16. Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy.
Hayano K; Watanabe H; Ryuzaki T; Sawada N; Ohira G; Kano M; Uesato M; Matsubara H
Surg Case Rep; 2020 Sep; 6(1):219. PubMed ID: 32970254
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Unresectable Local Recurrence of Gastric Cancer Successfully Resected after Pre-Operative Chemotherapy with Trastuzumab].
Okubo S; Takahashi T; Miyazaki Y; Makino T; Kurokawa Y; Yamazaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2094-6. PubMed ID: 26805275
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis.
Jankowski C; Guiu S; Cortet M; Charon-Barra C; Desmoulins I; Lorgis V; Arnould L; Fumoleau P; Coudert B; Rouzier R; Coutant C; Reyal F
Breast Cancer Res Treat; 2017 Jan; 161(1):73-81. PubMed ID: 27807808
[TBL] [Abstract][Full Text] [Related]
19. Hopes and failures in front-line advanced HER2-positive gastric cancer therapy.
Kong F; Yao Y; Deng R; Li X; Jia Y
Anticancer Drugs; 2021 Aug; 32(7):675-680. PubMed ID: 33929993
[TBL] [Abstract][Full Text] [Related]
20. [Two cases of human epidermal growth factor receptor 2-positive advanced gastric cancer successfully treated with S-1, cisplatin, and trastuzumab combination therapy followed by curative resection].
Yasuyama A; Mikata S; Soma Y; Yoshikawa Y; Watase C; Kubota M; Miyake Y; Matsuura Y; Kim HM; Murakami M; Hirota M; Morishima H; Matsunami N; Hasegawa J; Miwa H; Nezu R
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2203-6. PubMed ID: 24394060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]